| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $113.3M | -4.7% |
| Cost of Revenue | $52.5M | +2.5% |
| Gross Profit | $60.8M | -10.1% |
| R&D Expense | $12.3M | +14.2% |
| SG&A Expense | $24.5M | +0.8% |
| Operating Income | -$6.9M | -435.6% |
| Pre-tax Income | -$9.2M | -6456.4% |
| Income Tax | $337K | +127.7% |
| Net Income | -$9.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.5M | -42.4% |
| Accounts Receivable | $16.7M | -23.5% |
| Inventory | $26.4M | -4.2% |
| Current Assets | $51.1M | -17.0% |
| Total Assets | $145.4M | -10.5% |
| Current Liabilities | $23.2M | -8.2% |
| Long-term Debt | $46.8M | -3.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.2M | -8.7% |
| Capital Expenditures | $1.6M | +33.1% |
| Investing Cash Flow | -$1.6M | -18.2% |
| Financing Cash Flow | -$2.8M | -1025.8% |
| Free Cash Flow | -$438K | -753.7% |
| -3204.2% |
| EPS (Basic) | -$0.23 | -2200.0% |
| Total Liabilities |
| $73.1M |
| -7.4% |
| Stockholders' Equity | $72.2M | -13.4% |